BIS — ProShares UltraShort Nasdaq Biotechnology

US equity
10.82 -2.70% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 10.53 · high 29.16

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day-2.70%
1 week-14.41%
1 month-21.05%
3 months-36.65%
6 months-36.95%
Year to date-42.97%
1 year-62.29%
3 years-74.69%
5 years-68.58%

Technicals

RSI 1417.9
vs 50-day avg-20.84%
vs 200-day avg-36.43%
Volatility 1y43.0%
Max drawdown 1y-63.90%
Avg volume 30d7.7K
Daily bars held2,674
History from2016-01-04

Dividends

Yield (trailing 12m)4.27%
Paid last 12m0.4620
Payments in 12m4
Paying since2018-09-26

Largest institutional holders

managervalueshares
SUSQUEHANNA INTERNATIONAL GROUP, LLP582.3K65.9K
Tower Research Capital LLC (TRC)23.4K2.6K
MORGAN STANLEY212
UBS Group AG91

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d47.7% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about BIS

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open BIS in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →